Best of the Healthy Skepticism Library
This page lists the best 8571 references in the Main Healthy Skepticism chosen by Peter Mansfield.
Click on the HSL (Health Skepticism Library) number for more details which may include an abstract or full text.
HSL15386
Go RS.
Issues Behind Disclosure of Conflicts of Interest
JAMA 2008 Dec 12;300(18)
http://jama.ama-assn.org/cgi/content/extract/300/18/2120-a?etoc
HSL15404
Lim CW, Kirikoshi T.
Understanding the effects of pharmaceutical promotion: a neural network approach guided by genetic algorithm-partial least squares.
Health Care Manag Sci 2008 Dec;11(4):359-72
http://www.ncbi.nlm.nih.gov/pubmed/18998595
HSL15391
Islam F.
Pipe dreamer.
BMJ 2008 Nov 12;337:a2236
http://www.bmj.com/cgi/content/extract/337/nov12_1/a2236?papetoc
HSL15383
Wilkes M, Johns M.
Informed Consent and Shared Decision-Making: A Requirement to Disclose to Patients Off-Label Prescriptions
PLoS Med 2008 Nov 11;5(11):223
Link to source with long URL
HSL15374
Jarvis LM.
The New Deal: Seeking closer ties, drug companies and universities shake up the model for research alliances
C&EN 2008 Nov 10;86(45):13-20
http://pubs.acs.org/cen/coverstory/86/8645cover.html
HSL15363
Hall J, Noyce P, Cantrill J.
Why do district nurse prescribers alter their prescribing patterns?
Br J Community Nurs. 2008 Nov 7;13(11):507-513
http://www.ncbi.nlm.nih.gov/pubmed/18981966
HSL15345
Singh S, Ernst E.
Trick or Treatment: The Undeniable Facts about Alternative Medicine
The New England Journal of Medicine 2008 Nov 6;359(19):2076-2077
http://content.nejm.org/cgi/content/short/359/19/2076?query=TOC
HSL15329
Ross JS, Nazem AG, Lurie P, Lackner JE, Krumholz HM.
Updated Estimates of Pharmaceutical Company Payments to Physicians in Vermont
JAMA 2008 Nov 5;300(17)
http://jama.ama-assn.org/cgi/content/extract/300/17/1998-a?etoc
HSL15330
Mitka M.
Direct-to-Consumer Advertising of Medical Devices Under Scrutiny
JAMA 2008 Nov 5;300(17):1985-1986.
http://jama.ama-assn.org/cgi/content/extract/300/17/1985?etoc
HSL15331
Tanne JH.
US senators inquire into ties between stent makers and doctors.
BMJ 2008 Nov 4;337:a2363
http://www.bmj.com/cgi/content/extract/337/nov04_3/a2363?papetoc
HSL15338
Kmietowicz Z.
FDA warns Bayer about illegally marketing two over the counter products containing aspirin
BMJ 2008 Nov 4;337
http://www.bmj.com/cgi/content/full/337/nov04_3/a2402
HSL15360
Montoya ID.
E-detailing: information technology applied to pharmaceutical detailing.
Expert Opin Drug Saf 2008 Nov;7(6):635-41
http://www.informapharmascience.com/doi/abs/10.1517/14740338.7.6.635
HSL15306
European Medicines Agency approves POM-to-P orlistat switch
The Pharmaceutical Journal 2008 Oct 30;281(495)
Link to source with long URL
HSL15309
Christakis NA.
Does this work for you?
BMJ 2008 Oct 30;337:a2281
http://www.bmj.com/cgi/content/extract/337/oct30_1/a2281
HSL15310
Kmietowicz Z.
GlaxoSmithKline to limit payments it makes to US doctors to $150,000 a year.
BMJ 2008 Oct 30;337:a2315
http://www.bmj.com/cgi/content/full/337/oct30_1/a2315
HSL15276
Fugh-Berman A, Melnick D.
Off-Label Promotion, On-Target Sales.
PLoS Med 2008 Oct 28;5(10):e210
Link to source with long URL
HSL15296
Timimi S, Jureidini J, Leo J.
NICE recommendations are not evidence based and could expose many to unnecessary harm.
BMJ 2008 Oct 28;337:a2284
http://www.bmj.com/cgi/content/extract/337/oct27_2/a2284?papetoc
HSL15299
So AD, Sampat BN, Rai AK, Cook-Deegan R, Reichman JH, Weissman R, Kapczynski A.
Is Bayh-Dole Good for Developing Countries? Lessons from the US Experience.
PLoS Biol. 2008 Oct 28;6(10):e262
Link to source with long URL
HSL15405
Wadman M.
Pharma payment probe widens its net.
Nature 2008 Oct 23;455(7216):1017
http://www.nature.com/news/2008/081022/full/4551017a.html
HSL15242
Dobson R.
Atorvastatin advertising misled over benefits for women, study claims
BMJ 2008 Oct 22;337:a2209 epub ahead of print
http://www.bmj.com/cgi/content/extract/337/oct22_1/a2209?papetoc
HSL15304
Giezen TJ, Mantel-Teeuwisse AK, Straus SM, Schellekens H, Leufkens HG, Egberts AC.
Safety-related regulatory actions for biologicals approved in the United States and the European Union.
JAMA 2008 Oct 22;300(16):1887-96
http://jama.ama-assn.org/cgi/content/full/300/16/1887
HSL15239
Tanne JH.
US university sets up conflict of interest office after investigation into drug company payments
BMJ 2008 Oct 21;337:a2200 epub ahead of print
http://www.bmj.com/cgi/content/extract/337/oct21_3/a2200
HSL15364
Freedhoff Y.
Vetting journal advertisements.
CMAJ 2008 Oct 21;179(9):931
Link to source with long URL
HSL15201
Editorial .
More than one bad apple
Nature 2008 Oct 16;455(7215):835
http://www.nature.com/nature/journal/v455/n7215/full/455835a.html
HSL15272
Hopkins Tanne J.
US psychiatrist steps down after questions about drug company payments.
BMJ 2008 Oct 16;337:a2088
http://www.bmj.com/cgi/content/full/337/oct16_1/a2088
HSL15210
Montori VM, Guyatt GH.
Progress in Evidence-Based Medicine
JAMA 2008 Oct 15;300(15):1814-1816
http://jama.ama-assn.org/cgi/content/full/300/15/1814
HSL15252
Hitchen L.
Drug firms and regulatory agencies must consider how drugs are used.
BMJ 2008 Oct 14;337:a2083
http://www.bmj.com/cgi/content/extract/337/oct14_1/a2083?papetoc
HSL15250
Ernst E.
Alternatives to debate: 'Treating evidence with contempt'.
BMJ 2008 Oct 13;337:a2063
http://www.bmj.com/cgi/content/extract/337/oct13_2/a2063?papetoc
HSL15269
Vitiello B.
Letters: Truly independent research? Treatment for Adolescents with Depression Study (TADS)
BMJ 2008 10 13;337
http://www.bmj.com/cgi/content/extract/337/oct13_2/a2070
HSL15204
Read all about it: media reports of drug studies
The Lancet 2008 Oct 11;372(9646):1274
Link to source with long URL
HSL15365
Read all about it: media reports of drug studies.
Lancet 2008 Oct 11;372(9646):1274
http://linkinghub.elsevier.com/retrieve/pii/S0140-6736(08)61529-9
HSL15229
Reynolds L, McKee M.
Factors influencing antibiotic prescribing in China: An exploratory analysis.
Health Policy 2008 Oct 10:epub ahead of print
http://linkinghub.elsevier.com/retrieve/pii/S0168-8510(08)00206-6
HSL15295
Young NS, Ioannidis JP, Al-Ubaydli O.
Why current publication practices may distort science.
PLoS Med 2008 Oct 7;5(10):e201
Link to source with long URL
HSL15141
Sakel M.
Truly independent research is impossible.
BMJ 2008 Oct 1;337:a1881
http://www.bmj.com/cgi/content/full/337/oct01_3/a1881
HSL15163
Hochman M, Hochman S, Bor D, McCormic D.
Reporting Pharmaceutical Company Funding and Use of Generic Medication Names
JAMA 2008 Oct 1;300(13):1544-1550.
http://jama.ama-assn.org/cgi/content/abstract/300/13/1544?etoc
HSL15205
Hochman M, Hochman S, Bor D, McCormick D.
News Media Coverage of Medication Research
JAMA 2008 Oct 1;300(13):1544-1550.
http://jama.ama-assn.org/cgi/content/abstract/300/13/1544?etoc
HSL15317
Kvesic DZ.
Product lifecycle management: marketing strategies for the pharmaceutical industry
Journal of Medical Marketing 2008 Oct 1(8):293–301
http://www.palgrave-journals.com/jmm/journal/v8/n4/abs/jmm200823a.html
HSL15366
Colley P.
More on ads in veterinary publications.
J Am Vet Med Assoc. 2008 Oct 1;233(7):1059
http://www.ncbi.nlm.nih.gov/pubmed/18839493
HSL15179
Cutrona SL, Woolhandler S, Lasser KE, Bor DH, Himmelstein DU, Shrank WH, LeLeiko NS.
Free drug samples in the United States: characteristics of pediatric recipients and safety concerns.
Pediatrics 2008 Oct;122(4):736-42
http://pediatrics.aappublications.org/cgi/content/full/122/4/736
HSL15114
Martell J.
Buy me, I’ll change your life
Student BMJ 2008 Oct;16(350):10
http://student.bmj.com/issues/08/10/life/350.php
HSL15196
Vitry A.
Time for transparency at the TGA
Australian Prescriber 2008 Oct;31:114-6
http://www.australianprescriber.com/magazine/31/5/114/6/
HSL15197
Rutter P, Gilbody S.
The European pharmaceutical industry: coming to a screen near you?
J R Soc Med 2008 Oct;101(10):485-8
http://jrsm.rsmjournals.com/cgi/content/full/101/10/485
HSL15209
Kyle GJ, Nissen LM, Tett SE.
Pharmaceutical company influences on medication prescribing and their potential impact on quality use of medicines.
J Clin Pharm Ther 2008 Oct;33(5):553-9
http://www3.interscience.wiley.com/journal/121411215/abstract
HSL15228
Baker-Smith CM, Benjamin DK Jr, Grabowski HG, Reid ED, Mangum B, Goldsmith JV, Murphy MD, Edwards R, Eisenstein EL, Sun J, Califf RM, Li JS.
The economic returns of pediatric clinical trials of antihypertensive drugs.
Am Heart J 2008 Oct;156(4):682-8
http://linkinghub.elsevier.com/retrieve/pii/S0002-8703(08)00351-7
HSL15232
Eichler HG, Pignatti F, Flamion B, Leufkens H, Breckenridge A.
Balancing early market access to new drugs with the need for benefit/risk data: a mounting dilemma.
Nat Rev Drug Discov 2008 Oct;7(10):818-26
http://www.nature.com/nrd/journal/v7/n10/abs/nrd2664.html
HSL15277
Wadman M.
Straight talk with...Charles Grassley
Nature Medicine 2008 Oct;14(10):1006 - 1007
http://www.nature.com/nm/journal/v14/n10/full/nm1008-1006.html
HSL15336
Hall DV, Jones SC.
Australian consumer responses to DTCA and other pharmaceutical company sponsored advertisements.
Aust N Z J Public Health 2008 Oct;32(5):471-8
http://www.ncbi.nlm.nih.gov/pubmed/18959553
HSL15361
Palmer JA, Timm AR, Neumann PJ.
Drug company advertising in medical journals about the health-economic advantages of their products for 2000-2006 versus 1990-1999.
J Manag Care Pharm 2008 Oct;14(8):749-55
http://www.amcp.org/data/jmcp/749-755.pdf
HSL15403
Washlick JR, Welch SS.
Physician-vendor marketing and financial relationships under attack.
J Health Life Sci Law 2008 Oct;2(1):151,
http://www.ncbi.nlm.nih.gov/pubmed/19004300
HSL15318
Alkhateeb FM, Clauson KA, Khanfar NM, Latif DA.
Legal and regulatory risk associated with Web 2.0 adoption by pharmaceutical companies
Journal of Medical Marketing 2008 Sep 26(8):311–318
http://www.palgrave-journals.com/jmm/journal/v8/n4/abs/jmm200820a.html
HSL15116
Zito JM, Safer DJ, de Jong-van den Berg LT, Janhsen K, Fegert JM, Gardner JF, Glaeske G, Valluri SC.
A three-country comparison of psychotropic medication prevalence in youth.
Child and Adolescent Psychiatry and Mental Health 2008 Sep 25;2(1):26
http://www.capmh.com/content/2/1/26
HSL15135
Renfrew M, Hall D.
Enabling women to breast feed.
BMJ 2008 Sep 25;337:a1570
http://www.bmj.com/cgi/content/full/337/sep25_2/a1570
HSL15278
Hĺkansson J, Hernborg A, Olsson P.
[Advertising or science?]
Lakartidningen 2008 Sep 24-30;105(39):2710
http://www.ncbi.nlm.nih.gov/pubmed/18846885
HSL15136
Moncrieff J, Thomas P, Huws R.
Some progress in UK psychiatry.
BMJ 2008 Sep 23;337:a1780
http://www.bmj.com/cgi/content/extract/337/sep23_2/a1780
HSL15138
Ramogi MO.
Who else but pharma will fund medical education?
BMJ 2008 Sep 23;337:a1778
http://www.bmj.com/cgi/content/extract/337/sep23_2/a1778
HSL15139
Mathew JL.
Matters arising from industry link to education.
BMJ 2008 Sep 23;337:a1781
http://www.bmj.com/cgi/content/extract/337/sep23_2/a1781
HSL15140
Bamji AN.
More reasons for caution with statins and other such.
BMJ 2008 Sep 23;337:a1782
http://www.bmj.com/cgi/content/full/337/sep23_2/a1782
HSL15231
Eaton L.
Europeans claim industry handouts are not a problem.
CMAJ 2008 Sep 23;179(7):642-3
http://www.cmaj.ca/cgi/content/full/179/7/642
HSL15091
Van Zee A.
The Promotion and Marketing of OxyContin: Commercial Triumph, Public Health Tragedy.
Am J Public Health. 2008 Sep 17
http://www.ncbi.nlm.nih.gov/pubmed/18799767
HSL15230
Bernadotte K, Bergström R.
[MSD and LIF on marketing studies: all clinical trials can be used in marketing]
Lakartidningen. 2008 Sep 17;105(38):2594-5
http://www.ncbi.nlm.nih.gov/pubmed/18846867
HSL15118
Hall DV.
High levels of confusion for cholesterol awareness campaigns.
MJA 2008 Sep 15;189(6):326-8
http://www.mja.com.au/public/issues/189_06_150908/hal10349_fm.html
HSL15190
Lindberg M.
[Ezetimibe=cost effectiveness. Science or a debate contribution from MSD?]
Ugeskr Laeger. 2008 Sep 15;170(38):2987
http://www.ncbi.nlm.nih.gov/pubmed/18816890
HSL15049
Reed T.
The new Access to Medicine Index
The Lancet 2008 Sep 13;372(9642):890-891
Link to source with long URL
HSL15119
Ali MK, Narayan KM.
The new Access to Medicine Index.
Lancet 2008 Sep 13;372(9642):891
http://linkinghub.elsevier.com/retrieve/pii/S0140-6736(08)61396-3
HSL15120
Reed T.
The new Access to Medicine Index.
Lancet 2008 Sep 13;372(9642):890-1
http://linkinghub.elsevier.com/retrieve/pii/S0140-6736(08)61395-1
HSL15055
Eichler HG, Pignatti F, Flamion B, Leufkens H, Breckenridge A.
Balancing early market access to new drugs with the need for benefit/risk data: a mounting dilemma.
Nat Rev Drug Discov 2008 Sep 12:epub ahead of print
http://www.nature.com/nrd/journal/vaop/ncurrent/abs/nrd2664.html
HSL15054
White C.
Academics draft protocol for handling research misconduct
BMJ 2008 Sep 11;337:a1612
http://www.bmj.com/cgi/content/extract/337/sep11_1/a1612
HSL15070
Ghaemi SN, Shirzadi AA, Filkowski M.
Publication Bias and the Pharmaceutical Industry: The Case of Lamotrigine in Bipolar Disorder
Medscape J Med 2008 Sep 10;10(9):211
http://www.medscape.com/viewarticle/579046
HSL15159
Pickar D, Vinik J, Bartko JJ.
Pharmacotherapy of Schizophrenic Patients: Preponderance of Off-Label Drug Use
PLoS One 2008 Sep 10;3(9):3150
http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0003150
HSL15036
Barennes H, Andriatahina T, Latthaphasavang V, Anderson M, Srour LM, .
Misperceptions and misuse of Bear Brand coffee creamer as infant food: national cross sectional survey of consumers and paediatricians in Laos
BMJ 2008 Sep 9;337
http://www.bmj.com/cgi/content/abstract/337/sep09_2/a1379
HSL15087
Jorgensen AW, Maric KL, Tendal B, Faurschou A, Gotzsche PC.
Industry-supported meta-analyses compared with meta-analyses with non-profit or no support: Differences in methodological quality and conclusions.
BMC Med Res Methodol 2008 Sep 9;8(1):60
http://www.biomedcentral.com/1471-2288/8/60
HSL15121
Barennes H, Andriatahina T, Latthaphasavang V, Anderson M, Srour LM.
Misperceptions and misuse of Bear Brand coffee creamer as infant food: national cross sectional survey of consumers and paediatricians in Laos.
BMJ 2008 Sep 9;337:a1379
http://www.bmj.com/cgi/content/full/337/sep09_2/a1379
HSL15032
Jara M.
Spanish doctors say 'no thank you' to drug industry gifts
BMJ 2008 Sep 8;337
http://www.bmj.com/cgi/content/extract/337/sep08_1/a1579?papetoc
HSL15069
Conen D, Torres J, Ridker PM.
Differential Citation Rates of Major Cardiovascular Clinical Trials According to Source of Funding. A Survey From 2000 to 2005
Circulation. 2008 Sep 8:epub ahead of print
Link to source with long URL
HSL15072
Eisenberg T, Wells MT.
Statins and Adverse Cardiovascular Events in Moderate-Risk Females: A Statistical and Legal Analysis with Implications for FDA Preemption Claims
Journal of Empirical Legal Studies 2008 Sep 5;5(3):507 - 550
http://www3.interscience.wiley.com/journal/121400492/abstract
HSL15319
Bates AK.
Implementing a pre-launch named patient programme: Evidence of increased market share
Journal of Medical Marketing 2008 Sep 4(8):319–324
http://www.palgrave-journals.com/jmm/journal/v8/n4/abs/jmm200825a.html
HSL14980
Rothman DJ, Chimonas S.
New Developments in Managing Physician-Industry Relationships
JAMA 2008 Sep 3;300(9):1067
http://jama.ama-assn.org/cgi/content/extract/300/9/1067
HSL14982
Relman AS.
Industry Support of Medical Education
JAMA 2008 Sep 3;300(9):1071-1073
http://jama.ama-assn.org/cgi/content/extract/300/9/1071
HSL15056
Maisonneuve H, Touboul C, Bonnelye G, Bertrand D.
[French hospital doctors attend many educational programmes but have organisational and financial difficulties for their continuing medical education.]
Presse Med 2008 Sep 3:epub ahead of print
http://www.em-consulte.com/article/181774
HSL15097
Ross K.
Crackdown on unproven cancer treatments focuses on internet marketers.
J Natl Cancer Inst. 2008 Sep 3;100(17):1200-2
http://jnci.oxfordjournals.org/cgi/content/full/100/17/1200
HSL15122
Lee AC, Radford J.
The ranibizumab saga of drug profiteering.
BMJ 2008 Sep 3;337:a1532
http://www.bmj.com/cgi/content/full/337/sep03_3/a1532
HSL14978
Piwowar HA, Becich BJ, Bilofsky H, Crowley RS.
Towards a Data Sharing Culture: Recommendations for Leadership from Academic Health Centers
PLoS Med. 2008 Sep 2;5(9)
Link to source with long URL
HSL14981
Angell M.
Industry-Sponsored Clinical Research: A Broken System
JAMA 2008 Sep 2;300(9):1069
http://jama.ama-assn.org/cgi/content/extract/300/9/1069
HSL14985
Law MR, Majumdar SR, Soumerai SB, .
Effect of illicit direct to consumer advertising on use of etanercept, mometasone, and tegaserod in Canada: controlled longitudinal study
BMJ 2008 Sep 2;337
http://www.bmj.com/cgi/content/abstract/337/sep02_1/a1055
HSL14986
Mintzes B.
Direct to consumer advertising of prescription drugs
BMJ 2008 Sep 2;337
http://www.bmj.com/cgi/content/extract/337/sep02_1/a985
HSL14935
Sufrin CB, Ross JS.
Pharmaceutical Industry Marketing: Understanding Its Impact on Women's Health.
Obstet Gynecol Surv. 2008 Sep;63(9):585-596
Link to source with long URL
HSL14955
Editorial .
Credibility crisis in pediatric psychiatry
Nature Neuroscience 2008 Sep;11(9):983
http://www.nature.com/neuro/journal/v11/n9/index.html
HSL15006
Jones K.
In whose interest? Relationships between health consumer groups and the pharmaceutical industry in the UK.
Sociol Health Illn. 2008 Sep;30(6):929-43
Link to source with long URL
HSL15007
Abraham J.
Sociology of pharmaceuticals development and regulation: a realist empirical research programme.
Sociol Health Illn. 2008 Sep;30(6):869-85
http://www3.interscience.wiley.com/journal/121390260/abstract
HSL15009
Conrad P, Leiter V.
From Lydia Pinkham to Queen Levitra: direct-to-consumer advertising and medicalisation.
Sociol Health Illn 2008 Sep;30(6):825-38
http://www3.interscience.wiley.com/journal/121390265/abstract
HSL15030
Miller DP, Mansfield RJ, Woods JB, Wofford JL, Moran WP.
The Impact of Drug Samples on Prescribing to the Uninsured.
South Med J. 2008 Sep;101(9):888-893
Link to source with long URL
HSL15042
Downey LV.
What is the impact of free drug samples on patients?
South Med J 2008 Sep;101(9):879-80
Link to source with long URL
HSL15096
Smith PB, Benjamin DK Jr, Murphy MD, Johann-Liang R, Iyasu S, Gould B, Califf RM, Li JS, Rodriguez W.
Safety monitoring of drugs receiving pediatric marketing exclusivity.
Pediatrics 2008 Sep;122(3):e628-33
http://pediatrics.aappublications.org/cgi/content/full/122/3/e628
HSL15115
Liesegang TJ.
Commercialism, Loss of Professionalism, and the Effect on Journals
Archives of Ophthalmology 2008 Sep;126(9):1292-1295.
http://archopht.ama-assn.org/cgi/content/extract/126/9/1292
HSL15117
Zhang Y.
Cost-saving effects of olanzapine as long-term treatment for bipolar disorder.
The Journal of Mental Health Policy and Economics 2008 Sep;11(3):135-46
Link to source with long URL
HSL15124
Coleman DL.
Establishing policies for the relationship between industry and clinicians: lessons learned from two academic health centers.
Acad Med. 2008 Sep;83(9):882-7
Link to source with long URL
HSL15125
Liesegang TJ, Albert DM, Schachat AP.
How to ensure our readers' trust: the proper attribution of authors and contributors.
Am J Ophthalmol. 2008 Sep;146(3):337-40
http://linkinghub.elsevier.com/retrieve/pii/S0002-9394(08)00459-5
HSL15233
Steiner TJ.
Ethical issues arising from commercial sponsorship and from relationships with the pharmaceutical industry--report and recommendations of the Ethics Subcommittee of the International Headache Society.
Cephalalgia 2008 Sep;28:Suppl 3:1-25
http://www3.interscience.wiley.com/cgi-bin/fulltext/120776174/PDFSTART
HSL15279
Miao-Sheng C, Yu-Ti S.
Pricing of prescription drugs and its impact on physicians' choice behavior.
Health Care Manag Sci 2008 Sep;11(3):288-95
http://www.ncbi.nlm.nih.gov/pubmed/18826006
HSL15337
Strehl E.
[Surveillance--more than a marketing instrument?].
Med Monatsschr Pharm. 2008 Sep;31(9):346-50
http://www.ncbi.nlm.nih.gov/pubmed/18831466
HSL15367
Tomaszewski C.
Blinding in peer review.
J Med Toxicol. 2008 Sep;4(3):147-8
Link to source with long URL
HSL15401
Mastroianni FC, Noto AR.
Newsmaking on drugs: a qualitative study with journalism professionals.
J Psychoactive Drugs 2008 Sep;40(3):293-300
http://www.ncbi.nlm.nih.gov/pubmed/19004421
HSL15005
Gulhati CM.
Illegal Approval to Market Letrozole for Infertility in India
Monthly Index of Medical Specialities - India 2008 Aug 31
HSL15008
Fox NJ, Ward KJ.
Pharma in the bedroom. . . and the kitchen. . . . The pharmaceuticalisation of daily life
Sociol Health Illn 2008 Aug 28;30(6):856 - 868
http://www3.interscience.wiley.com/journal/121390267/abstract
HSL15123
Dompé S.
Changes in the rules now governing Italy's drug industry.
Nature 2008 Aug 28;454(7208):1049
http://www.nature.com/doifinder/10.1038/4541049c
HSL15353
Williams SJ, Gabe J, Davis P.
The sociology of pharmaceuticals: progress and prospects
Sociology of Health & Illness 2008 Aug 28;30(6):813 - 824
Link to source with long URL
HSL15011
Lachenbruch PA, Wasserstein R.
Guest authorship, mortality reporting, and integrity in rofecoxib studies.
JAMA 2008 Aug 27;300(8):904
http://jama.ama-assn.org/cgi/content/full/300/8/904
HSL15012
Maisonneuve H.
Guest authorship, mortality reporting, and integrity in rofecoxib studies.
JAMA 2008 Aug 27;300(8):903
http://jama.ama-assn.org/cgi/content/full/300/8/903
HSL15013
Ong HT, Cheah JS.
Guest authorship, mortality reporting, and integrity in rofecoxib studies.
JAMA 2008 Aug 27;300(8):903-4
http://jama.ama-assn.org/cgi/content/full/300/8/903-a
HSL15014
Balon R.
Guest authorship, mortality reporting, and integrity in rofecoxib studies.
JAMA 2008 Aug 27;300(8):902
http://jama.ama-assn.org/cgi/content/full/300/8/902
HSL15015
Costa SD.
Guest authorship, mortality reporting, and integrity in rofecoxib studies.
JAMA 2008 Aug 27;300(8):902-3
http://jama.ama-assn.org/cgi/content/full/300/8/902-a
HSL15016
Patrono C.
Guest authorship, mortality reporting, and integrity in rofecoxib studies.
JAMA 2008 Aug 27;300(8):901
http://jama.ama-assn.org/cgi/content/full/300/8/901
HSL15017
Hawkey CJ.
Guest authorship, mortality reporting, and integrity in rofecoxib studies.
JAMA 2008 Aug 27;300(8):901
http://jama.ama-assn.org/cgi/content/full/300/8/901-a
HSL15018
Ferris S, Galasko D, Kirby L.
Guest authorship, mortality reporting, and integrity in rofecoxib studies.
JAMA 2008 Aug 27;300(8):901-2
http://jama.ama-assn.org/cgi/content/full/300/8/901-b
HSL15019
Johnson KR, Lassere MN.
Guest authorship, mortality reporting, and integrity in rofecoxib studies.
JAMA 2008 Aug 27;300(8):900
http://jama.ama-assn.org/cgi/content/full/300/8/900
HSL15020
FitzGerald GA.
Guest authorship, mortality reporting, and integrity in rofecoxib studies.
JAMA 2008 Aug 27;300(8):900-1
http://jama.ama-assn.org/cgi/content/full/300/8/900-a
HSL15213
Hariz M.
[Medically dangerous advertising of Treo].
Lakartidningen. 2008 Aug 27-Sep;105(35):2349
http://www.ncbi.nlm.nih.gov/pubmed/18833634
HSL15214
Forslund L, Gerdén B.
[It's only afterwards the Medical Products Agency can scrutinize advertisements].
Lakartidningen. 2008 Aug 27-Sep;105(35):2348
http://www.ncbi.nlm.nih.gov/pubmed/18833633
HSL15022
Gould M.
End of the free lunch?
BMJ 2008 Aug 26;337:a1399
http://www.bmj.com/cgi/content/full/337/aug26_1/a1399
HSL14925
Kim JJ, Goldie SJ.
Health and Economic Implications of HPV Vaccination in the United States.
NEJM 2008 Aug 21;359(8):821-32
http://content.nejm.org/cgi/content/full/359/8/821
HSL15023
Lenzer J.
Truly independent research?
BMJ 2008 Aug 21;337:a1332
http://www.bmj.com/cgi/content/full/337/aug21_1/a1332
HSL14934
Dumville JC, Petherick ES, O'Meara S, Raynor P, Cullum N.
How is research evidence used to support claims made in advertisements for wound care products?
J Clin Nurs 2008 Aug 20
Link to source with long URL
HSL14906
Hill KP, Ross JS, Egilman DS, Krumholz HM.
The ADVANTAGE seeding trial: a review of internal documents.
Annals of Internal Medicine 2008 Aug 19;149(4):251-8
http://www.annals.org/cgi/content/full/149/4/251
HSL14909
Sox HC, Rennie D.
Seeding trials: just say 'no'
Annals of Internal Medicine 2008 Aug 19;149(4):279-80
http://www.annals.org/cgi/content/full/149/4/279
HSL14913
Moynihan R.
Is the relationship between pharma and medical education on the rocks?
BMJ 2008 Aug 14;337:a925
http://www.bmj.com/cgi/content/short/337/aug14_1/a925
HSL14914
Fletcher S.
Pharma and CME: View from the US.
BMJ 2008 Aug 14;337:a1023
http://www.bmj.com/cgi/content/short/337/aug14_1/a1023
HSL14915
Pisacane A.
Rethinking continuing medical education.
BMJ 2008 Aug 14;337:a973
http://www.bmj.com/cgi/content/short/337/aug14_1/a973
HSL14933
Mastroianni PC, Vaz AC, Noto AR, Galduróz JC.
[Psychoactive drug advertising: content analysis].
Rev Saude Publica. 2008 Aug 14
Link to source with long URL
HSL14971
Kormeset PO.
[Pharmaceutical consultants and drug information].
Tidsskr Nor Laegeforen 2008 Aug 14;128(15):1684-5
http://www.tidsskriftet.no/index.php?vp_SEKS_ID=1716767
HSL15137
Moynihan R.
Is the relationship between pharma and medical education on the rocks?
BMJ 2008 Aug 14;337:a925
http://www.bmj.com/cgi/content/extract/337/aug14_1/a925
HSL14895
Kermode-Scott B.
Harm from prescription drugs likely to grow, claims US sociologist.
BMJ 2008 Aug 13;337:a1280
http://www.bmj.com/cgi/content/full/337/aug13_3/a1280
HSL15191
Meijman FJ.
[Health communication and public media: professionals need to be heard].
Ned Tijdschr Geneeskd. 2008 Aug 9;152(32):1760-4
http://www.ncbi.nlm.nih.gov/pubmed/18754306
HSL14865
Editorial .
Clean hands, please
Nature 2008 Aug 7;454(7205):667
http://www.nature.com/nature/journal/v454/n7205/full/454667b.html
HSL15098
Clean hands, please.
Nature 2008 Aug 7;454(7205):667
http://www.nature.com/doifinder/10.1038/454667b
HSL14845
Reed SD, Anstrom KJ, Seils DM, .
Use Of Larger Versus Smaller Drug-Safety Databases Before Regulatory Approval: The Trade-Offs
Health Affairs 2008 Aug 5
http://content.healthaffairs.org/cgi/content/full/hlthaff.27.5.w360/DC1
HSL14867
Tanne JH.
FDA oversight of drug company promotion of off-label use is poor, US watchdog says.
BMJ 2008 Aug 5;337:a1163
http://www.bmj.com/cgi/content/full/337/aug05_2/a1163
HSL14869
Bandler LG.
Misleading advertising of PI-based drug information?
Med J Aust. 2008 Aug 4;189(3):181
http://www.mja.com.au/public/issues/189_03_040808/letters_040808_fm-5.html
HSL14720
Chauhan D, Mason A.
Factors affecting the uptake of new medicines in secondary care - a literature review.
J Clin Pharm Ther 2008 Aug;33(4):339-48
Link to source with long URL
HSL14848
Doucet M, Sismondo S.
Evaluating solutions to sponsorship bias.
BMJ 2008 Aug;34(8):627-30
http://jme.bmj.com/cgi/content/abstract/34/8/627
HSL14870
Berger E.
Ghostwriters, data manipulation and dollar diplomacy: how drug companies pull the strings in clinical research.
Ann Emerg Med. 2008 Aug;52(2):137-9
http://www.ncbi.nlm.nih.gov/pubmed/18672488
HSL14898
Vincent WR, Wiesner AM, Steinke DT.
'Free' prescription drug samples are not free.
Am J Public Health. 2008 Aug;98(8):1348-9
http://www.ajph.org/cgi/content/full/98/8/1348
HSL14938
Whitehead J, Cobo E.
Stopping a trial early in oncology: for patients or for industry?
Ann Oncol. 2008 Aug;19(8):1512-3
http://annonc.oxfordjournals.org/cgi/content/full/19/8/1512-a
HSL15283
Torrey EF.
A question of disclosure.
Psychiatr Serv 2008 Aug;59(8):935
http://ps.psychiatryonline.org/cgi/content/full/59/8/935
HSL15406
Ratner M, Gura T.
Off-label or off-limits?
Nature 2008 Aug;26(8):867-75
http://www.nature.com/nbt/journal/v26/n8/abs/nbt0808-867.html
HSL15407
Mitchell P.
UK strong arms industry over drug pricing.
Nat Biotechnol. 2008 Aug;26(8):846-7
http://www.nature.com/doifinder/10.1038/nbt0808-846c
HSL14832
Troy DE, Gottlieb S.
Pharmaceutical promotion and First Amendment rights.
N Engl J Med 2008 Jul 31;359(5):536
http://www.ncbi.nlm.nih.gov/pubmed/18669437
HSL14861
Kuriya B, Schneid EC, Bell CM.
Quality of Pharmaceutical Industry Press Releases Based on Original Research
PLoS ONE 2008 July 30;3(7):e2828
http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0002828
HSL14834
Gilstad JR, Finucane TE.
Results, Rhetoric, and Randomized Trials: The Case of Donepezil.
J Am Geriatr Soc. 2008 Jul 24
Link to source with long URL
HSL14753
Lenzer J, Brownlee S.
Naming names: is there an (unbiased) doctor in the house?
BMJ 2008 Jul 23;337
http://www.bmj.com/cgi/content/extract/337/jul23_3/a930
HSL15010
Linnersten L.
[Is household-targeted Gardasil advertising in accordance with the intentions of the legislators?].
Lakartidningen. 2008 Jul 23;105(30-31):2121
http://www.ncbi.nlm.nih.gov/pubmed/18751457
HSL14871
Tanne JH.
Senator asks psychiatrists' association about drug company funding.
BMJ 2008 Jul 21;337:a929
http://www.bmj.com/cgi/content/full/337/jul21_2/a929
HSL15192
Reeve JF, Mackson JM, Sweidan M, Williamson M.
The effect of advertising in clinical software on general practitioners' prescribing behaviour.
Med J Aust 2008 Jul 21;189(2):85
http://www.mja.com.au/public/issues/189_02_210708/ree10190_fm.html
HSL14742
Al-Marzouki S, Roberts I, Evans S, Marshall T.
Selective reporting in clinical trials: analysis of trial protocols accepted by The Lancet
The Lancet 2008 Jul 19;372(9634):201
Link to source with long URL
HSL14743
McNamee D, James A, Kleinert S.
Protocol review at The Lancet
The Lancet 2008 Jul 19;372(9634):189-190
Link to source with long URL
HSL14778
Abel GA, Neufeld EJ, Sorel M, Weeks JC.
Direct-to-consumer advertising for bleeding disorders: a content analysis and expert evaluation of advertising claims.
J Thromb Haemost 2008 Jul 18
http://www3.interscience.wiley.com/journal/120835477/abstract
HSL14761
Sorensen L, Gyrd-Hansen D, Kristiansen IS, Nexoe J, Nielsen JB.
Laypersons' understanding of relative risk reductions: a randomised cross-sectional study.
BMC Med Inform Decis Mak 2008 Jul 17;8(1):31
http://www.biomedcentral.com/1472-6947/8/31
HSL14839
Dobson R.
Roche is suspended from ABPI for 'actions likely to bring discredit' on the industry.
BMJ 2008 Jul 16;337:a835
http://www.bmj.com/cgi/pmidlookup?view=long&pmid=18632675
HSL14794
The PLoS Medicine Editors.
Next Stop, Don't Block the Doors: Opening Up Access to Clinical Trials Results.
PLoS Med. 2008 Jul 15;5(7):e160
Link to source with long URL
HSL14835
Reynolds CJ, Yates T, Hughes R.
Key opinion leaders: Getting them while they're young.
BMJ 2008 Jul 15;337:a792
http://www.bmj.com/cgi/pmidlookup?view=long&pmid=18632710
HSL14836
Spiers AS.
Key opinion leaders: How to spot one.
BMJ 2008 Jul 15;337:a790
http://www.bmj.com/cgi/pmidlookup?view=long&pmid=18632709
HSL14837
Fugh-Berman A.
Key opinion leaders: Thus are our medical meetings managed.
BMJ 2008 Jul 15;337:a789
http://www.bmj.com/cgi/pmidlookup?view=long&pmid=18632708
HSL14838
Carroll BJ.
How it really works.
BMJ 2008 Jul 15;337:a788
http://www.bmj.com/cgi/pmidlookup?view=long&pmid=18632707
HSL14872
Kaufert P, Kaufert J.
Distressing news on the Therapeutics Initiative.
CMAJ 2008 Jul 15;179(2):164
Link to source with long URL
HSL14873
Hébert PC.
Direct-to-consumer advertising: end the compromise.
CMAJ 2008 Jul 15;179(2):119
Link to source with long URL
HSL14897
Marek K.
Reader objects to increasing ads in veterinary publications.
J Am Vet Med Assoc 2008 Jul 15;233(2):224-5
http://www.ncbi.nlm.nih.gov/pubmed/18642410
HSL14779
Dyer C.
Prosecution over drug price fixing collapses.
BMJ 2008 Jul 14;337:a814
http://www.bmj.com/cgi/content/full/337/jul14_2/a814
HSL14780
Tanne JH.
Pfizer stops funding medical education provided by profit making companies.
BMJ 2008 Jul 8;337:a708
http://www.bmj.com/cgi/content/full/337/jul08_2/a708
HSL14781
Stafford N.
German watchdog investigates drug company's online education courses.
BMJ 2008 Jul 8;337:a723
http://www.bmj.com/cgi/content/full/337/jul08_1/a723
HSL14782
Tanne JH.
US doctors display
BMJ 2008 Jul 8;337:a711
http://www.bmj.com/cgi/content/full/337/jul08_1/a711
HSL15217
Radcliff M.
'We should question the power of drug companies'.
Nurs Times. 2008 Jul 8-14;104(27):52
http://www.ncbi.nlm.nih.gov/pubmed/18683392
HSL14896
West D.
The frequency of medicines advertising on New Zealand television.
N Z Med J 2008 Jul 4;121(1277):97-8
http://www.ncbi.nlm.nih.gov/pubmed/18677339
HSL14783
Tuffs A.
German soap opera has thinly veiled references to branded drugs, regulator says.
BMJ 2008 Jul 1;337:a619
http://www.bmj.com/cgi/pmidlookup?view=long&pmid=18595910
HSL14840
Brooks JR.
Pens, mugs, clocks, notepads and other handouts.
CMAJ 2008 Jul 1;179(1):28-9
Link to source with long URL
HSL14841
Holloway RG, Mooney CJ, Getchius TS, Edlund WS, Miyasaki JO.
Invited Article: Conflicts of interest for authors of American Academy of Neurology clinical practice guidelines.
Neurology 2008 Jul 1;71(1):57-63
http://www.neurology.org/cgi/content/full/71/1/57
HSL14874
Rosenberg RN.
Unreported financial disclosures.
Arch Neurol 2008 Jul;65(7):992
http://archneur.ama-assn.org/cgi/content/full/65/7/992
HSL14876
Bastawrous A, Smith MC.
We are part of the problem.
Br J Ophthalmol 2008 Jul;92(7):1010
http://bjo.bmj.com/cgi/content/full/92/7/1010
HSL14969
Islam MS, Farah SS.
Sources of information in drug advertisements: evidence from the drug indexing journal of Bangladesh.
Indian J Med Ethics 2008 Jul-Sep;5(3):136-7
http://www.ncbi.nlm.nih.gov/pubmed/18754240
HSL14973
Tyndall A.
Why do we need noncommercial, investigator-initiated clinical trials?
Nature 2008 Jul;4(7):354-5
http://www.nature.com/doifinder/10.1038/ncprheum0814
HSL15103
Somberg JC.
The sins of ghostwriting.
Am J Ther 2008 Jul-Aug;15(4):297-8
Link to source with long URL
HSL15215
Rivkees SA.
The long arm of financial conflicts of interest: extensions into lined pockets, research and review, and the United States Senate.
J Pediatr Endocrinol Metab. 2008 Jul;21(7):607-9
http://www.ncbi.nlm.nih.gov/pubmed/18780592
HSL15368
McHenry LB, Jureidini JN.
Industry-sponsored ghostwriting in clinical trial reporting: a case study.
Account Res 2008 Jul-Sep;15(3):152-67
http://www.ncbi.nlm.nih.gov/pubmed/18792536
HSL15369
Nayak BK.
Finer nuances of clinical study agreements for research trials.
Indian J Ophthalmol 2008 Jul-Aug;56(4):267-8
Link to source with long URL
HSL14784
Moynihan R.
Drug maker's PR firm is force behind blood clot awareness campaign.
BMJ 2008 Jun 28;336(7659):1460-1
http://www.bmj.com/cgi/content/full/336/7659/1460-a
HSL14760
Kaiser J.
Ethics. Senate inquiry on research conflicts shifts to grantees
Science. 2008 Jun 27;320(5884):1708
http://www.sciencemag.org/cgi/content/full/320/5884/1708
HSL14693
Cowen PJ.
Serotonin and depression: pathophysiological mechanism or marketing myth?
Trends Pharmacol Sci. 2008 Jun 26
Link to source with long URL
HSL15216
Wink K.
[Do patients understand special terms in the product information?]
MMW Fortschr Med. 2008 Jun 26;150
http://www.ncbi.nlm.nih.gov/pubmed/18712123
HSL14773
Cain DM, Detsky AS.
Everyone's a Little Bit Biased (Even Physicians)
JAMA. 2008 Jun 25;299(24):2893-2895
Link to source with long URL
HSL14573
Moynihan R.
Key opinion leaders: independent experts or drug representatives in disguise?
BMJ 2008 Jun 21;336(7658):1402-3
http://www.bmj.com/cgi/content/extract/336/7658/1402
HSL14574
Godlee F.
Key opinion leaders, your time is up
BMJ 2008 Jun 21;336(7658)
http://www.bmj.com/cgi/content/extract/336/7658/0
HSL14575
Buckwell C.
Should the drug industry work with key opinion leaders? Yes
BMJ 2008 Jun 21;336(7658):1404
http://www.bmj.com/cgi/content/full/336/7658/1404
HSL14576
Fava GA.
Should the drug industry work with key opinion leaders? No
BMJ 2008 Jun 21;336(7658):1405
http://www.bmj.com/cgi/content/full/336/7658/1405
HSL14767
Jack A.
Europe's drug companies are better than those in US in making drugs accessible to poor countries.
BMJ 2008 Jun 21;336(7658):1396
http://www.bmj.com/cgi/content/extract/336/7658/1396
HSL14695
Fitzgerald GA.
Drugs, industry, and academia.
Science. 2008 Jun 20;320(5883):1563
http://www.sciencemag.org/cgi/content/full/320/5883/1563
HSL14562
Titus SL, Wells JA, Rhoades LJ.
Repairing research integrity
Nature 2008 Jun 19;453:980-982
http://www.nature.com/nature/journal/v453/n7198/full/453980a.html
HSL14581
Tinetti ME.
Over-the-counter sales of statins and other drugs for asymptomatic conditions.
N Engl J Med 2008 Jun 19;358(25):2728-32
http://content.nejm.org/cgi/content/extract/358/25/2728
HSL14828
Ledford H.
Institutes in pharma cash probe.
Nature 2008 Jun 19;453(7198):963
http://www.nature.com/news/2008/080618/full/453963a.html
HSL14829
[No authors listed].
Anti-AIDS vitamin advertising banned.
Nature 2008 Jun 19;453(7198):969
http://www.nature.com/news/2008/080618/full/453969c.html
HSL14830
Mejia R.
Taking the industry road.
Nature 2008 Jun 19;453(7198):1138-9
http://www.nature.com/naturejobs/2008/080619/full/nj7198-1138a.html
HSL14567
Ledford H.
Institutes in pharma cash probe: Universities under pressure to investigate researchers' industry funding.
Nature 2008 Jun 18;453(963)
http://www.nature.com/news/2008/080618/full/453963a.html
HSL14641
Kuehn BM.
Companies’ Use of Web to Recruit Patients for Studies Brings Opportunities, Risks
JAMA 2008 Jun 18;299(23):2733
http://jama.ama-assn.org/cgi/content/full/299/23/2733
HSL14543
Vollmar HC, Ostermann T, Hinz A, Rieger MA, Butzlaff ME.
[Primary care physicians, internet and educational media. Preferences, usages and appraisal in a 6-year comparison]
Med Klin (Munich). 2008 Jun 15;103(6):425-32
http://www.ncbi.nlm.nih.gov/pubmed/18548212
HSL14537
Editorial .
Direct-to-consumer advertising under a different name
The Lancet 2008 Jun 14;371(9629):1972
Link to source with long URL
HSL14608
Lenzer J.
Review launched after Harvard psychiatrist failed to disclose industry funding.
BMJ 2008 Jun 14;336(7657):1327
Link to source with long URL
HSL14646
Direct-to-consumer advertising under a different name.
Lancet 2008 Jun 14;371(9629):1972
http://linkinghub.elsevier.com/retrieve/pii/S0140-6736(08)60843-0
HSL14763
Winkler JT.
Law on unjustified health claims: Member states must enforce ban on dubious products.
BMJ 2008 Jun 14;336(7657):1324-5
http://www.bmj.com/cgi/content/extract/336/7657/1324-c
HSL14541
Gérvas J.
Human papillomavirus vaccines. Three decent proposals .
CMAJ 2008 Jun 13:epub
http://www.cmaj.ca/cgi/eletters/177/12/1527
HSL14629
Goozner M.
A prescription for public health
Nature 2008 Jun 12;453:855-856
http://www.nature.com/nature/journal/v453/n7197/full/453855a.html
HSL14623
Light D.
Missing the real issue about the pneumo AMC
Development Today 2008 Jun 11;XVIII(8):11
http://www.development-today.com/magazine/2008/DT_8/Opinion/3490
HSL14513
Moynihan R.
Independent drug watchdog in Canada under funding threat
BMJ 2008 Jun 7;336(7656):1270
http://www.bmj.com/cgi/content/extract/336/7656/1270-a
HSL14514
Burton B.
Drug industry weakens US bill about disclosure of gifts
BMJ 2008 Jun 7;336(7656):1268
http://www.bmj.com/cgi/content/extract/336/7656/1268-a
HSL14765
Hickman L.
Product placement in the waiting room.
BMJ 2008 Jun 7;336(7656):1274-5
http://www.bmj.com/cgi/content/extract/336/7656/1274
HSL14766
Tanne JH.
US branded drug makers pay to prevent generic competition.
BMJ 2008 Jun 7;336(7656):1266-7
http://www.bmj.com/cgi/content/extract/336/7656/1266-b
HSL14546
Lichter PR.
Debunking Myths in Physician-Industry Conflicts of Interest.
Am J Ophthalmol. 2008 Jun 5
http://linkinghub.elsevier.com/retrieve/pii/S0002-9394(08)00276-6
HSL14530
Stockigt JR.
Misleading advertising of PI-based drug information?
Med J Aust 2008 Jun 2;188(11):679-80
http://www.mja.com.au/public/issues/188_11_020608/letters_020608_fm-6.html
HSL15393
Javitt G, Berkowitz D, Gostin LO.
Assessing Mandatory HPV Vaccination: Who Should Call the Shots?
The Journal of Law, Medicine & Ethics 2008 Jun 2;36(2):384 - 395
Link to source with long URL
HSL14786
Cudny ME, Graham AS.
Adverse-drug-event data provided by pharmaceutical companies.
Am J Health Syst Pharm. 2008 Jun 1;65(11):1071-5
http://www.ajhp.org/cgi/content/full/65/11/1071
HSL14339
Mastroianni PC, Noto AR, Galduróz JC.
[Psychoactive drug advertising: analysis of scientific information].
Rev Saude Publica 2008 Jun;42(3):epub ahead of print
Link to source with long URL
HSL14586
Lado E, Vacariza M, Fernández-González C, Gestal-Otero JJ, Figueiras A.
Influence exerted on drug prescribing by patients' attitudes and expectations and by doctors' perception of such expectations: a cohort and nested case-control study.
J Eval Clin Pract. 2008 Jun;14(3):453-9
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2753.2007.00901.x
HSL14605
Sharma AM.
Response
Can Fam Physician 2008 Jun;54(6):849 - 850
http://www.cfp.ca/cgi/content/full/54/6/849?etoc
HSL14606
Kelsall DL.
Editor’s response
Can Fam Physician 2008 Jun;54(6):850 - 851
http://www.cfp.ca/cgi/content/full/54/6/850?etoc
HSL14604
Lexchin J, Basset K, Biron P, Mansfield PR, Mintzes B.
Medications for obesity
Can Fam Physician 2008 Jun;54(6):848 - 849
http://www.cfp.ca/cgi/content/full/54/6/848-a?etoc
HSL14643
Green S.
Ethics and the pharmaceutical industry.
Australas Psychiatry. 2008 Jun;16(3):158-65
Link to source with long URL
HSL14692
Tavcar R, Dernovsek MZ.
Clinically tested toothpaste and other fairy tales - A critical approach to reading pharmaceutical advertisements and professional papers.
Psychiatr Danub 2008 Jun;20(2):249-50
http://www.ncbi.nlm.nih.gov/pubmed/18587300
HSL14746
Bhangale V.
Pharma marketing in India: Opportunities, challenges and the way forward
Journal of Medical Marketing 2008 Jun;8(3):205–210
http://www.palgrave-journals.com/jmm/journal/v8/n3/abs/5050121a.html
HSL14748
Joseph M, Spake DF, Godwin DM.
Aging consumers and drug marketing: Senior citizens' views on DTC advertising, the medicare prescription drug programme and pharmaceutical retailing
Journal of Medical Marketing 2008 Jun;8(3):221–228
http://www.palgrave-journals.com/jmm/journal/v8/n3/abs/jmm20084a.html
HSL14749
Singh R.
Network connectedness of pharmaceutical sales rep (FLE)-physician dyad and physician prescription behaviour: A conceptual model
J Med Market 2008 Jun;8(3):257-268
http://www.palgrave-journals.com/jmm/journal/v8/n3/abs/jmm200814a.html
HSL14759
Whittle J, Good CB.
Prescription drug samples: making decisions with imperfect data.
J Gen Intern Med 2008 Jun;23(6):890-2
http://www.springerlink.com/content/246544r5343x74t6/fulltext.pdf
HSL14788
Tjia J, Briesacher BA, Soumerai SB, Pierre-Jacques M, Zhang F, Ross-Degnan D, Gurwitz JH.
Medicare beneficiaries and free prescription drug samples: a national survey.
J Gen Intern Med. 2008 Jun;23(6):709-14
http://www.springerlink.com/content/9871685172880q62/
HSL14790
Luevorasirikul K, Gray NJ, Anderson CW.
Developing a consumer evaluation tool of weight control strategy advertisements on the Internet.
Health Educ Res. 2008 Jun;23(3):567-75
http://her.oxfordjournals.org/cgi/content/full/23/3/567
HSL14820
Lexchin J.
Doctors and Industry Funding of Continuing Medical Education: Guilty as Charged
The Israeli Journal of Emergency Medicine 2008 Jun;8(2):23-25
http://isrjem.org/Isrjem_June08.Funding%20Lexchin_Postprod.pdf
HSL14972
Hammerschmidt D.
Bias in the design, interpretation, and publication of industry-sponsored clinical research.
Minn Med. 2008 Jun;91(6):46-7
http://www.ncbi.nlm.nih.gov/pubmed/18616022
HSL14995
Joseph M, Spake DF, Godwin DM.
Aging consumers and drug marketing: Senior citizens’ views on DTC advertising, the medicare prescription drug programme and pharmaceutical retailing.
Journal of Medical Marketing 2008 Jun;8(3):221-228
Link to source with long URL
HSL15024
Tsai HJ.
Physician-industry interactions: there is no such thing as a free lunch.
Taiwan J Obstet Gynecol 2008 Jun;47(2):252-5
http://ajws.elsevier.com/ajws3/abstract.asp?art_id=4411&art_journals=5
HSL15025
Loncarek K.
How to say 'thanks' in Phoenician.
Croat Med J. 2008 Jun;49(3):441-3
Link to source with long URL
HSL15057
Kerridge I.
Comment: interactions between the medical profession and the pharmaceutical industry in Australia.
Australas Psychiatry 2008 Jun;16(3):166-8
Link to source with long URL
HSL15058
Green S.
Ethics and the pharmaceutical industry.
Australas Psychiatry 2008 Jun;16(3):158-65
Link to source with long URL
HSL15099
Kohr R.
Taking issue with 'lets do lunch.'
Can Nurse. 2008 Jun;104(6):5-6
http://www.ncbi.nlm.nih.gov/pubmed/18646299
HSL15100
Macdonald G.
Taking issue with 'lets do lunch.'
Can Nurse. 2008 Jun;104(6):5
http://www.ncbi.nlm.nih.gov/pubmed/18646298
HSL15101
Meyouhas V.
Taking issue with 'lets do lunch.'
Can Nurse. 2008 Jun;104(6):5
http://www.ncbi.nlm.nih.gov/pubmed/18646297
HSL15102
Gheseger J.
Taking issue with 'lets do lunch.'
Can Nurse. 2008 Jun;104(6):5
http://www.ncbi.nlm.nih.gov/pubmed/18646296
HSL15104
McCall J.
Taking issue with "Let's do lunch".
Can Nurse 2008 Jun;104(6):5
http://www.ncbi.nlm.nih.gov/pubmed/18642492
HSL15105
McCall J.
Taking issue with 'Let's do lunch'.
Can Nurse. 2008 Jun;104(6):5
http://www.ncbi.nlm.nih.gov/pubmed/18642492
HSL15111
Lloyd S.
Morals, medicine and change: morality brokers, social phobias, and French psychiatry.
Cult Med Psychiatry. 2008 Jun;32(2):279-97
http://www.springerlink.com/content/hh8k583l8p1r375t/
HSL15131
Sandall J.
No such thing as a free lunch.
Midwifery. 2008 Jun;24(2):123-5
Link to source with long URL
HSL15218
Fisher JA.
Practicing research ethics: private-sector physicians & pharmaceutical clinical trials.
Soc Sci Med. 2008 Jun;66(12):2495-505
Link to source with long URL
HSL15281
Rohra DK, Bashir MU, Khwaja UA, Nazir MR.
Critical appraisal of apparently evidence-based written advertising in Pakistan.
Pharm World Sci 2008 Jun;30(3):216-21
http://www.springerlink.com/content/c1576830414g6157/
HSL15370
Bucher HC.
[Surrogate endpoint trials: benefit and pitfalls for clinical decision making].
Internist (Berl). 2008 Jun;49(6):681-7
http://www.springerlink.com/content/k127706732328k06/
HSL14547
Charatan F.
Merck to pay $58m in settlement over rofecoxib advertising.
BMJ 2008 May 31;336(7655):1208-9
http://www.bmj.com/cgi/content/full/336/7655/1208-a
HSL14638
Silversides A.
Highly-lauded drug assessment program under attack.
CMAJ 2008 May 28
http://www.cmaj.ca/cgi/content/full/179/1/26?etoc
HSL14485
Ioannidis JP.
Effectiveness of antidepressants: an evidence myth constructed from a thousand randomized trials?
Philos Ethics Humanit Med 2008 May 27;3:14
http://www.peh-med.com/content/3/1/14
HSL14687
PLoS Medicine Editors, Barbour V, Clark J, Peiperl L, Veitch E, Wong M, Yamey G.
False hopes, unwarranted fears: the trouble with medical news stories.
PLoS Med. 2008 May 27;5(5):e118
Link to source with long URL
HSL14688
Schwitzer G.
How do US journalists cover treatments, tests, products, and procedures? An evaluation of 500 stories
PLoS Med. 2008 May 27;5(5):95
Link to source with long URL
HSL14689
Moynihan R, Doran E, Henry D.
Disease mongering is now part of the global health debate.
PLoS Med. 2008 May 27;5(5):e106
Link to source with long URL
HSL14756
Watson R.
New law bans selling of products with unjustified health claims
BMJ 2008 May 24;336(7654):1150
http://www.bmj.com/cgi/content/extract/336/7654/1150-a?etoc
HSL14757
Moszynski P.
Alliance aims to help health workers in poor countries challenge corruption, excessive pricing, and waste of drugs
BMJ 2008 May 24;336(7654):1155
http://www.bmj.com/cgi/content/extract/336/7654/1155-a?etoc
HSL14758
Mayor S.
Cancer charity starts research programme with drug "borrowed" from industry
BMJ 2008 May 24;336(7654):1155
http://www.bmj.com/cgi/content/extract/336/7654/1155-c?etoc
HSL14458
Montgomery BD, Mansfield PR, Spurling GK, Ward AM.
Do advertisements for antihypertensive drugs in Australia promote quality prescribing? A cross-sectional study
BMC Public Health 2008 May 20;8(1):167 [Epub ahead of print]
http://www.biomedcentral.com/content/pdf/1471-2458-8-167.pdf
HSL14419
Day M.
Drug industry is partly to blame for overdiagnosis of bipolar disorder, researchers claim.
BMJ 2008 May 17;336(7653):1092-3
http://www.bmj.com/cgi/content/extract/336/7653/1092
HSL14486
Dyer O.
Drug companies must be open about using doctors as consultants, new code of practice demands.
BMJ 2008 May 17;336(7653):1095
http://www.bmj.com/cgi/content/extract/336/7653/1095-c
HSL14457
De Jonge, Bockting CL.
Selective Publication of Antidepressant Trials
NEJM 2008 May 15;358(20):2180-2182
http://content.nejm.org/cgi/content/extract/358/20/2180
HSL14648
Schwarz LR.
Industry promotion of unlabeled uses.
Am J Health Syst Pharm. 2008 May 15;65(10):908-10
http://www.ajhp.org/cgi/content/full/65/10/908
HSL14940
Chon SH, Lösche P, Christ H, Lehmacher W, Griebenow R.
[Comparative evaluation of sponsored and unsponsored continuing medical education].
Med Klin (Munich). 2008 May 15;103(5):341-5
http://www.ncbi.nlm.nih.gov/pubmed/18484220
HSL14390
Boden WE, Diamond GA.
DTCA for PTCA — Crossing the Line in Consumer Health Education?
NEJM 2008 May 22;358(21):2197-200
http://content.nejm.org/cgi/content/full/NEJMp0801433
HSL14393
Fugh-Berman A.
Prescription Tracking and Public Health
Journal of General Internal Medicine 2008 May 13:epub ahead of print
http://www.blackwell-synergy.com/loi/JGI
HSL14420
Donohue JM, Fischer MA, Huskamp HA, Weissman JS.
Potential Savings from an Evidence-Based Consumer-Oriented Public Education Campaign on Prescription Drugs.
Health Serv Res 2008 May 13
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1475-6773.2008.00858.x
HSL14511
Fugh-Berman A.
Prescription Tracking and Public Health.
J Gen Intern Med 2008 May 13:epub ahead of print
http://www.springerlink.com/content/w332410717763632/
HSL14361
Montgomery BD.
Free lunches are not the answer
BMJ 2008 May 10;336(7652):1034
Link to source with long URL
HSL14489
Tanne JH.
US medical schools should say no to pharma support.
BMJ 2008 May 10;336(7652):1035
http://www.bmj.com/cgi/content/extract/336/7652/1035
HSL14490
Sie AH.
Why I love a free lunch: You must be joking.
BMJ 2008 May 10;336(7652):1034
http://www.bmj.com/cgi/content/extract/336/7652/1034-c
HSL14661
Bergström S, Aronsson A.
Misoprostol in resource poor countries.
BMJ 2008 May 10;336(7652):1032
http://www.bmj.com/cgi/content/extract/336/7652/1032?etoc
HSL14398
Weinfurt KP, Seils DM, Tzeng JP, Lin L, Schulman KA, Califf RM.
Consistency of Financial Interest Disclosures in the Biomedical Literature: The Case of Coronary Stents
PLoS ONE 2008 May 7;3(5):e2128
http://www.plosone.org/article/info:doi%2F10.1371%2Fjournal.pone.0002128
HSL14694
Bergström R.
[The journals must honestly tell who is doing the job].
Lakartidningen. 2008 May 7-13;105(19):1406-7
http://www.ncbi.nlm.nih.gov/pubmed/18574981
HSL14352
Collier J.
An end in sight for the secretive drug price fixing pact between government and industry
BMJ Blogs 2008 May 6
Link to source with long URL
HSL14460
Kamerow D.
Who wrote that article?
BMJ 2008 May 3;336(7651):989
http://www.bmj.com/cgi/content/full/336/7651/989
HSL14461
Mathew JL.
Global access to vaccines: Vaccine science and commerce: never the twain shall meet?
BMJ 2008 May 3;336(7651):974
http://www.bmj.com/cgi/content/extract/336/7651/974-b
HSL14475
Puliyel JM, Shrivastava A.
Global access to vaccines: Poor nations are being lured into a debt trap
BMJ 2008 May 3;336(7651):974
http://www.bmj.com/cgi/content/extract/336/7651/974-c?etoc
HSL14476
Mathew A.
Global access to vaccines: Vaccine sale is not tailored to improving India’s health
BMJ 2008 May 3;336(7651):975
http://www.bmj.com/cgi/content/extract/336/7651/975?etoc
HSL14477
Mittal O.
Global access to vaccines: Vaccine requirements compete with basic needs of poor people
BMJ 2008 May 3;336(7651):975
http://www.bmj.com/cgi/content/extract/336/7651/975-a?etoc
HSL14478
Stafford N.
MEPs shun cancer advocacy group because of industry funding
BMJ 2008 May 3;336(7651):980
http://www.bmj.com/cgi/content/extract/336/7651/980-a?etoc
HSL14374
Fortuna RJ, Ross-Degnan D, Finkelstein J, Zhang F, Campion FX, Simon SR.
Clinician attitudes towards prescribing and implications for interventions in a multi-specialty group practice.
J Eval Clin Pract 2008 May 2
Link to source with long URL
HSL14560
Haug C.
[Ghostwriting].
Tidsskr Nor Laegeforen 2008 May 1;128(9):1039
http://www.tidsskriftet.no/index.php?vp_SEKS_ID=1683144
HSL13804
Sismondo S.
How pharmaceutical industry funding affects trial outcomes: Causal structures and responses.
Soc Sci Med 2008 May Epub 2008 Ma;66(9):1909-14
Link to source with long URL
HSL14173
Civaner M, Sarikaya O, Alici SU, Bozkurt G.
Exposing nursing students to the marketing methods of pharmaceutical companies.
Nurs Ethics 2008 May;15(3):396-410
http://nej.sagepub.com/cgi/content/abstract/15/3/396
HSL14309
Jureidini JN, McHenry LB, Mansfield PR.
Clinical trials and drug promotion: Selective reporting of study 329
The International Journal of Risk and Safety in Medicine 2008 May;20(1-2):73-81
Link to source with long URL
HSL14319
Burashnikova IS, Ziganshin AU, Ziganshina LE.
Attitudes to pharmaceutical promotion techniques among healthcare professionals in the Republic of Tatarstan, Russia
The International Journal of Risk and Safety in Medicine 2008 May;20(1-2):57-71
Link to source with long URL
HSL14370
Kirkpatrick JS, Stevens T.
The FDA process for the evaluation and approval of orthopaedic devices.
J Am Acad Orthop Surg 2008 May;16(5):260-7
http://www.jaaos.org/cgi/content/abstract/16/5/260
HSL14373
Varenicline for smoking cessation
Drug and Therapeutics Bulletin 2008 May;46(5):33-36
http://dtb.bmj.com/cgi/content/abstract/46/5/33
HSL14423
Berger E.
Leak: Avandia and the integrity of the peer review process.
Ann Emerg Med 2008 May;51(5):636-8
http://www.annemergmed.com/article/S0196-0644(08)00603-3/fulltext
HSL14467
Sajid MS, Iftikhar M, Monteiro RS, Miles AF, Woods WG, Baig MK.
Internet information on colorectal cancer: commercialization and lack of quality control.
Colorectal Dis 2008 May;10(4):352-6
http://www.ncbi.nlm.nih.gov/pubmed/17645570
HSL14493
McLennan M, Leong FC, Steele A, Harris J.
The influence of industry sponsorship on the acceptance of abstracts and their publication.
Am J Obstet Gynecol 2008 May;198(5):579
http://linkinghub.elsevier.com/retrieve/pii/S0002-9378(07)02344-7
HSL14529
Turkoski BB.
Drugs used to treat erectile dysfunction.
Orthop Nurs 2008 May-Jun;27(3):201-4
Link to source with long URL
HSL14531
Gura T.
Courts deny Pfizer access.
Nat Biotechnol 2008 May;26(5):480
http://www.nature.com/doifinder/10.1038/nbt0508-480
HSL14550
Knapp S, Vandecreek L.
The ethics of advertising, billing, and finances in psychotherapy.
J Clin Psychol 2008 May;64(5):613-25
Link to source with long URL
HSL14696
Garnier JP.
Rebuilding the R&D engine in big pharma.
Harv Bus Rev. 2008 May;86(5):68-70,
http://www.ncbi.nlm.nih.gov/pubmed/18543809
HSL14697
Mamdani M, Ching A, Golden B, Melo M, Menzefricke U.
Challenges to evidence-based prescribing in clinical practice.
Ann Pharmacother. 2008 May;42(5):704-7
http://www.theannals.com/cgi/content/full/42/5/704
HSL14787
Cairns A, Yarker YE.
The role of healthcare communications agencies in maintaining compliance when working with the pharmaceutical industry and healthcare professionals.
Curr Med Res Opin. 2008 May;24(5):1371-8
Link to source with long URL
HSL14941
Cesario J, Higgins ET.
Making message recipients
Psychol Sci 2008 May;19(5):415-20
http://www3.interscience.wiley.com/journal/119410470/abstract
HSL14974
Miller DR.
Disclosure of conflicts of interest in biomedical publications.
Can J Anaesth 2008 May;55(5):265-7,
http://www.ncbi.nlm.nih.gov/pubmed/18451113
HSL15106
Stockigt JR.
Comparison of consumer medication information in the United States, Europe, and Australia.
J Am Pharm Assoc 2008 May-Jun;48(3):326
Link to source with long URL
HSL15109
Howland RH.
The need to guard against pharmaceutical industry influence.
Psychiatr Serv 2008 May;59(5):566
http://ps.psychiatryonline.org/cgi/content/full/59/5/566
HSL15110
Arbuckle MR, Gameroff MJ, Marcus SC, West JC, Wilk J, Olfson M.
Psychiatric opinion and antipsychotic selection in the management of schizophrenia.
Psychiatr Serv. 2008 May;59(5):561-5
http://ps.psychiatryonline.org/cgi/content/full/59/5/561
HSL15354
Williams SJ, Seale C, Boden S, Lowe P, Steinberg DL.
Waking up to sleepiness: Modafinil, the media and the pharmaceuticalisation of everyday/night life
Sociology of Health & Illness 2008 Apr 28;30(6):839 - 855
http://www3.interscience.wiley.com/journal/120121716/abstract
HSL14360
Patel K.
Why I love a free lunch
BMJ 2008 Apr 26;336(7650):962
http://www.bmj.com/cgi/content/extract/336/7650/962-a
HSL14376
Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, Schünemann HJ.
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
BMJ 2008 Apr 26;336(7650):924
http://www.bmj.com/cgi/content/extract/336/7650/924?etoc
HSL14377
Spence D.
X ray specs
BMJ 2008 Apr 26;336(7650):962
http://www.bmj.com/cgi/content/extract/336/7650/962
HSL14340
Psaty BM, Ray W.
FDA guidance on off-label promotion and the state of the literature from sponsors.
JAMA 2008 Apr 23;299(16):1949-51
http://jama.ama-assn.org/cgi/content/full/299/16/1949
HSL14877
Silversides A.
Abramson: direct-to-consumer advertising will erode health care.
CMAJ 2008 Apr 22;178(9):1126-7
Link to source with long URL
HSL14270
Editorial .
Stopping trials early for benefit: too good to be true
The Lancet 2008 Apr 19;371(9621):1310
Link to source with long URL
HSL14311
Tanne JH.
Merck used ghostwriters and selective data in Vioxx publications, JAMA says.
BMJ 2008 Apr 19;336(7649):849
http://www.bmj.com/cgi/content/full/336/7649/849
HSL14469
Burton B.
Australian drug industry seeks to improve its image
BMJ 2008 Apr 19;336(7649):850
http://www.bmj.com/cgi/content/extract/336/7649/850-a
HSL14470
Lenzer J.
Direct to Consumer Genetic Testing: Knowing me, knowing you
BMJ 2008 Apr 19;336(7649):858-860
http://www.bmj.com/cgi/content/extract/336/7649/858
HSL14278
Kesselheim AS, Avorn J.
Pharmaceutical promotion to physicians and first amendment rights.
NEJM 2008 Apr 17;358(16):1727-32
http://content.nejm.org/cgi/content/extract/358/16/1727
HSL14463
Cressey D.
Merck accused of disguising its role in research.
Nature 2008 Apr 17;452(7189):791
http://www.nature.com/news/2008/080416/full/452791b.html
HSL14260
Psaty BM, Kronmal RA.
Reporting mortality findings in trials of rofecoxib for Alzheimer disease or cognitive impairment: a case study based on documents from rofecoxib litigation.
JAMA 2008 Apr 16;299(15):1813-7
http://jama.ama-assn.org/cgi/content/full/299/15/1813
HSL14261
DeAngelis CD, Fontanarosa PB.
Impugning the integrity of medical science: the adverse effects of industry influence.
JAMA 2008 Apr 16;299(15):1833-5
http://jama.ama-assn.org/cgi/content/extract/299/15/1833
HSL14262
Mitka M.
Critics say FDA's off-label guidance allows marketing disguised as science.
JAMA 2008 Apr 16;299(15):1759-61
http://jama.ama-assn.org/cgi/content/extract/299/15/1759
HSL14273
Ross JS, Hill KP, Egilman DS, Krumholz HM.
Guest authorship and ghostwriting in publications related to rofecoxib: a case study of industry documents from rofecoxib litigation.
JAMA 2008 Apr 16;299(15):1800-12
http://jama.ama-assn.org/cgi/content/full/299/15/1800
HSL14471
Leff B, Finucane TE.
Gizmo Idolatry
JAMA. 2008 Apr 16;299(15):1830-1832
http://jama.ama-assn.org/cgi/content/extract/299/15/1830
HSL14248
Howe RA.
Don't include trimethoprim.
BMJ 2008 Apr 12;336(7648):787
http://www.ncbi.nlm.nih.gov/pubmed/18403503
HSL14249
Medawar C.
A cynical consultation exercise?
BMJ 2008 Apr 12;336(7648):787
http://www.bmj.com/cgi/content/extract/336/7648/787-a?etoc
HSL14250
Glaser AN.
Include cost of treatment.
BMJ 2008 Apr 12;336(7648):788
http://www.bmj.com/cgi/content/extract/336/7648/788?etoc
HSL14251
Burton B.
Roche fined for breaching direct to consumer advertising ban and publishing unbalanced advertisements.
BMJ 2008 Apr 12;336(7648):792
http://www.bmj.com/cgi/content/extract/336/7648/792?etoc
HSL14252
Watson R.
EC proposals fail to distinguish between information and advertising.
BMJ 2008 Apr 12;336(7648):792-3
http://www.bmj.com/cgi/content/extract/336/7648/792-b?etoc
HSL14253
Jack A.
Donors agree financial arrangement to stimulate vaccine development
BMJ 2008 Apr 12;336(7648):797
http://www.bmj.com/cgi/content/extract/336/7648/797?etoc
HSL14254
Lenzer J.
Company’s decision to lengthen lipid lowering trial causes controversy
BMJ 2008 Apr 12;336(7648):797
http://www.bmj.com/cgi/content/extract/336/7648/797-a?etoc
HSL14208
Trotta F, Apolone G, Garattini S, Tafuri G.
Stopping a trial early in oncology: for patients or for industry?
Annals of Oncology 2008 Apr 9:epub ahead of print
http://annonc.oxfordjournals.org/cgi/content/full/mdn042v4
HSL14221
Chester MR, Bridson J.
When will NICE or the FDA make stent manufacturers prove they are not merely latter day snake oil salesmen?
BMJ 2008 Apr 9:epub
http://www.bmj.com/cgi/eletters/336/7647/743#193170
HSL14237
Kemper KJ, Hood KL.
Does pharmaceutical advertising affect journal publication about dietary supplements?
BMC Complement Altern Med. 2008 Apr 9;8(1):11
http://www.biomedcentral.com/1472-6882/8/11
HSL14425
Kemper KJ, Hood KL.
Does pharmaceutical advertising affect journal publication about dietary supplements?
BMC Complement Altern Med 2008 Apr 9;8:11
Link to source with long URL
HSL14224
Simmonds H.
It takes two to tango
BMJ 2008 Apr 8:epub
http://www.bmj.com/cgi/eletters/336/7647/776#193296
HSL14151
Sweet M.
Academic freedom is at risk in dispute over Gardasil, lecturers say
BMJ 2008 Apr 5;336(7647):741
http://www.bmj.com/cgi/content/extract/336/7647/741-a
HSL14152
Burton B.
Australian drug industry gives details of money spent courting doctors
BMJ 2008 Apr 5;336(7647):742
http://www.bmj.com/cgi/content/extract/336/7647/742-a
HSL14168
Sale of infant cough medicines splutters to a halt
The Lancet 2008 Apr 5;371(9619):1138
Link to source with long URL
HSL14219
Aronson JK.
Too high a pedestal
BMJ 2008 Apr 5;336(7647):735
http://www.bmj.com/cgi/content/extract/336/7647/735
HSL14222
Lenzer J.
Longer, better studies of coronary stents are needed, FDA tells industry
BMJ 2008 Apr 5;336(7647):743
http://www.bmj.com/cgi/content/extract/336/7647/743
HSL14223
Spence D.
Bend it like . . . ?
BMJ 2008 Apr 5;336(7647):776
http://www.bmj.com/cgi/content/extract/336/7647/776
HSL14225
Farrell L.
The Best Medicine: Passion required
BMJ 2008 Apr 5;336(7647):776
http://www.bmj.com/cgi/content/extract/336/7647/776-a
HSL14226
Bewley S.
Getting to the bottom of evidence based medicine
BMJ 2008;336(7647):764 (5 April), 2008 Apr 5;336(7647):764
http://www.bmj.com/cgi/content/extract/336/7647/764
HSL14281
Sale of infant cough medicines splutters to a halt.
Lancet 2008 Apr 5;371(9619):1138
http://linkinghub.elsevier.com/retrieve/pii/S0140-6736(08)60497-3
HSL14341
Wijesinghe PR, Norris P.
Increased advertising of medicines on New Zealand television since 2001.
N Z Med J 2008 Apr 4;121(1271):121-2
http://www.ncbi.nlm.nih.gov/pubmed/18392070
HSL13822
Light DW.
Reply to DiMasi, Hansen, and Grabowski.
J Health Polit Policy Law 2008 Apr;33(2):325-7
http://jhppl.dukejournals.org/cgi/reprint/33/2/325?view=long&pmid=18325905
HSL13998
Alexander GC, Zhang J, Basu A.
Characteristics of Patients Receiving Pharmaceutical Samples and Association Between Sample Receipt and Out-of-Pocket Prescription Costs.
Medical Care 2008 Apr;46(4):394-402
Link to source with long URL
HSL14174
Schowalter JE.
How to manage conflicts of interest with industry?
Int Rev Psychiatry 2008 Apr;20(2):127-33
http://www.informaworld.com/smpp/content?content=10.1080/09540260801887728
HSL14177
Cross J.
DxS Ltd.
Pharmacogenomics 2008 Apr;9(4):463-7
http://www.futuremedicine.com/doi/abs/10.2217/14622416.9.4.463
HSL14235
Editorial .
A double-edged sword
Nature Reviews Drug Discovery 2008 Apr;7(4):275
http://www.nature.com/nrd/journal/v7/n4/index.html
HSL14275
Spielmans GI, Thielges SA, Dent AL, Greenberg RP.
The accuracy of psychiatric medication advertisements in medical journals.
J Nerv Ment Dis. 2008 Apr;196(4):267-73
Link to source with long URL
HSL14276
Matter A, Keller TH.
Impact of non-profit organizations on drug discovery: opportunities, gaps, solutions.
Drug Discov Today. 2008 Apr;13(7-8):347-52
Link to source with long URL
HSL14287
Sharfstein SS.
Big Pharma and American Psychiatry.
The Journal of Nervous and Mental Disease 2008 Apr;196(4):265
Link to source with long URL
HSL14299
Waldinger MD, Schweitzer DH.
Premature ejaculation and pharmaceutical company-based medicine: the dapoxetine case.
Journal of Sexual Medicine 2008 Apr;5(4):966-97
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1743-6109.2008.00633.x
HSL14300
Goldstein I.
Regarding Waldinger and Schweitzer's
J Sex Med 2008 Apr;5(4):965
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1743-6109.2008.00808.x
HSL14342
Alpert JS.
Doctors and the drug industry: further thoughts for dealing with potential conflicts of interest?
Am J Med 2008 Apr;121(4):253-5
http://linkinghub.elsevier.com/retrieve/pii/S0002-9343(08)00053-3
HSL14428
Mennuti M.
Are doctors prepared for direct-to-consumer advertising of genetic tests?
Obstet Gynecol 2008 Apr;111(4):991,
http://www.greenjournal.org/cgi/content/full/111/4/991
HSL14459
Hagen B, Pijl-Zieber EM, Souveny K, Lacroix A.
Lets Do Lunch? The ethics of accepting gifts from the pharmaceutical industry
Can Nurse. 2008 Apr;104(4):30-5
http://www.ncbi.nlm.nih.gov/pubmed/18488765
HSL14464
Alexander GC, Zhang J, Basu A.
Characteristics of patients receiving pharmaceutical samples and association between sample receipt and out-of-pocket prescription costs.
Med Care 2008 Apr;46(4):394-402
Link to source with long URL
HSL14494
Niebyl JR.
The pharmaceutical industry: friend or foe?
Am J Obstet Gynecol 2008 Apr;198(4):435-9
http://linkinghub.elsevier.com/retrieve/pii/S0002-9378(07)02228-4
HSL14533
Doran E, Henry DA.
Australian pharmaceutical policy: price control, equity, and drug innovation in Australia.
J Public Health Policy 2008 Apr;29(1):106-20
http://www.palgrave-journals.com/jphp/journal/v29/n1/full/3200170a.html
HSL14544
Gniady JA.
Regulating direct-to-consumer genetic testing: protecting the consumer without quashing a medical revolution.
Fordham Law Rev. 2008 Apr;76(5):2429-75
http://www.ncbi.nlm.nih.gov/pubmed/18546580
HSL14545
Pouillot R, Bilong C, Boisier P, Ciss M, Moumouni A, Amani I, Nabeth P.
[Illicit drug trade on the markets of Yaounde (Cameroon) and Niamey (Niger): characteristics of salesmen and quality of drugs].
Bull Soc Pathol Exot. 2008 Apr;101(2):113-8
http://www.ncbi.nlm.nih.gov/pubmed/18543704
HSL14561
Schowalter JE.
How to manage conflicts of interest with industry?
Int Rev Psychiatry. 2008 Apr;20(2):127-33
Link to source with long URL
HSL14617
Egilman DS, Bohme SR.
IJOEH and the critique of bias.
Int J Occup Environ Health 2008 Apr-Jun;14(2):147-51
http://www.ncbi.nlm.nih.gov/pubmed/18507293
HSL14649
Shankar PR.
PharmedOut.
Singapore Med J 2008 Apr;49(4):363-5
http://smj.sma.org.sg/4904/4904le2.pdf
HSL14723
Bell H.
Thanks, but no thanks.
Minn Med 2008 Apr;91(4):26-30
Link to source with long URL
HSL14725
Stout MM.
Reader feedback on commercialism in dentistry article.
J Calif Dent Assoc 2008 Apr;36(4):240
Link to source with long URL
HSL14726
Hordiner P, Saroyan J.
Readers Voice Concerns Over Ad
J Calif Dent Assoc 2008 Apr;36(4):240
Link to source with long URL
HSL14768
Robinson S, Delongeas JL, Donald E, Dreher D, Festag M, Kervyn S, Lampo A, Nahas K, Nogues V, Ockert D, Quinn K, Old S, Pickersgill N, Somers K, Stark C, Stei P, Waterson L, Chapman K.
A European pharmaceutical company initiative challenging the regulatory requirement for acute toxicity studies in pharmaceutical drug development.
Regul Toxicol Pharmacol 2008 Apr;50(3):345-52
Link to source with long URL
HSL14843
Davis JM, Chen N, Glick ID.
Issues that may determine the outcome of antipsychotic trials: industry sponsorship and extrapyramidal side effect.
Nature 2008 Apr;33(5):971-5
Link to source with long URL
HSL14899
Aitken P.
The ABPI code of practice: controls on the promotion of prescription medicines.
Clin Med. 2008 Apr;8(2):128-9
Link to source with long URL
HSL14937
Malhotra P.
The impact of TRIPS on innovation and exports: a case study of the pharmaceutical industry in India.
Indian J Med Ethics. 2008 Apr-Jun;5(2):61-5
http://www.ncbi.nlm.nih.gov/pubmed/18624153
HSL15128
Liu Y, Doucette WR.
Does direct-to-consumer advertising affect patients' choice of pain medications?
Curr Pain Headache Rep. 2008 Apr;12(2):89-93
http://www.ncbi.nlm.nih.gov/pubmed/18474186
HSL15193
Caldeira TR, Neves ER, Perini E.
[Historical evolution of package inserts in Brazil].
Cad Saude Publica 2008 Apr;24(4):737-43
Link to source with long URL
HSL15236
Light DW, Warburton RN.
Ethical Standards for Healthcare Journal Editors: A Case Report and Recommendations
Harvard Health Policy Review 2008 Spring;9(1):46-55
http://www.hhpr.org/currentissue/archives.php
HSL15280
de Wildt G, Khoon CC.
Patents or patients? Global access to pharmaceuticals and social justice
Med Confl Surviv. 2008 Apr;24(Suppl 1):S52-61
http://www.ncbi.nlm.nih.gov/pubmed/18771195
HSL14176
Compagni A, Cavalli L, Jommi C.
Pharmaceutical companies and Italian Regional Governments: Managing relationships in an increasing institutional complexity.
Health Policy 2008 Mar 31:epub ahead of print
http://linkinghub.elsevier.com/retrieve/pii/S0168-8510(08)00057-2
HSL14124
Jackevicius CA, Tu JV, Ross JS, Ko DT, Krumholz HM.
Use of Ezetimibe in the United States and Canada
NEJM 2008 Mar 30:epub ahead of print
http://content.nejm.org/cgi/content/full/NEJMsa0801461v1
HSL14141
Richards T.
Purely medicinal?
BMJ 2008 Mar 29;336(7646):693
http://www.bmj.com/cgi/content/extract/336/7646/693
HSL14214
Delamothe T.
Of medicine and medicines
BMJ 2008 Mar 29;336(7646)
http://www.bmj.com/cgi/content/full/336/7646/0
HSL14215
Cole A.
Drug industry anxious about scrapping price regulation scheme
BMJ 2008 Mar 29;336(7646):686
http://www.bmj.com/cgi/content/extract/336/7646/686-a
HSL14216
Mayor S.
Opening the lid on open access
BMJ 2008 Mar 29;336(7646):688
http://www.bmj.com/cgi/content/extract/336/7646/688
HSL14217
Dyer O.
GP advised patients to take pills made by company she worked for
BMJ 2008 Mar 29;336(7646):689
http://www.bmj.com/cgi/content/full/336/7646/689-e
HSL14218
Ferner RE, Beard K.
Over the counter medicines: proceed with caution
BMJ 2008 Mar 29;336(7646):694
http://www.bmj.com/cgi/content/full/336/7646/694
HSL14056
Carpenter D, Zucker EJ, Avorn J.
Drug-Review Deadlines and Safety Problems
NEJM 2008 Mar 27;358(13):1354-1361
http://content.nejm.org/cgi/content/abstract/358/13/1354
HSL14132
Hébert PC.
The need for an Institute of Continuing Health Education
CMAJ 2008 Mar 25;178(7):805-6, 809-810
http://www.cmaj.ca/cgi/content/full/178/7/805
HSL14137
Murray DM, Pals SL, Blitstein JL, Alfano CM, Lehman J.
Design and Analysis of Group-Randomized Trials in Cancer: A Review of Current Practices
JNCI 2008 Mar 25;100(7):483-491
http://jnci.oxfordjournals.org/cgi/content/abstract/100/7/483
HSL14647
Cranston L, Allen M, Bugden S, Nguyen A, Bunka D, Regier L, Bean T, Jin M, Campbell C, Marlow BA, Mongeau I, Stern S, Murray S, Becker AB, Marlow BA, Sinclair D, Falz S.
Funding for continuing medical education.
CMAJ 2008 Mar 25;178(7):805-6, 809-10
http://www.cmaj.ca/cgi/content/full/178/12/1578
HSL13999
DeAngelis CD, Thornton JP.
Preserving Confidentiality in the Peer Review Process
JAMA 2008 Mar 24;299(16):epub ahead of print
http://jama.ama-assn.org/cgi/content/full/299.16.jed80000
HSL14118
Reinarman C.
Cannabis policies and user practices: Market separation, price, potency, and accessibility in Amsterdam and San Francisco.
Int J Drug Policy 2008 Mar 24
http://www.ncbi.nlm.nih.gov/pubmed/18367390
HSL14210
Antonuccio DO, Healy D.
Moving beyond depression: The researcher’s credo
BMJ 2008 Mar 22;336(7645):629
http://www.bmj.com/cgi/content/extract/336/7645/629
HSL14211
Steer P.
Follies and Fallacies in Medicine
BMJ 2008 Mar 22;336(7645):673
http://www.bmj.com/cgi/content/extract/336/7645/673-a
HSL13936
Kaiser J.
Pfizer Denied Access to Journals' Files
Sci